REGN

Regeneron

$796.55

-4.46 (-0.56%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 11.01.2026
$824.69
(+3.53%)
Strong Buy: 3
Buy: 15
Hold: 8
Sell: 0
Strong Sell: 1
Description:
Regeneron Pharmaceuticals, Inc. is a prominent American biotechnology firm headquartered in Westchester County, New York, renowned for its pioneering work in monoclonal antibodies and therapeutic proteins. The company excels in various therapeutic areas, notably oncology, ophthalmology, and immunology, with leading products like Eylea and Dupixent contributing significantly to its growth. With a robust pipeline of innovative therapies in development, Regeneron is committed to advancing scientific research and addressing critical unmet medical needs, solidifying its influential position within the biopharmaceutical sector.
Exchange:
NASDAQ
Country:
USA
Sector:
HEALTHCARE
Industry:
BIOTECHNOLOGY
Address:
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, UNITED STATES, 10591-6707
Fiscal year end:
December
Market capitalization:
$84.4 Billion
EBITDA:
$4.35 Billion
PERatio:
19.08
EPS:
41.74
Dividend per share:
$2.64
Dividend yield:
0.33%
Beta:
0.389

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
+43%
How much will you get:
$1,430
Prices dates:
31-12-2015: $539.94 and 31-12-2025: $771.87